OMRON Completes Aratas Share Transfer to Carlyle-backed TCG2602

Executive Summary

• OMRON Corporation said the transfer of all issued and outstanding shares of Aratas Corporation to TCG2602 Co., Ltd., a wholly owned subsidiary of a company established by The Carlyle Group, was completed effective October 1, 2026. Source
• The absorption-type company split that moved the Device & Module Solutions business into Aratas took effect on July 1, 2026, as previously scheduled. Source
• OMRON also completed an equity investment giving it a 5% stake in TCG2601 Co., Ltd., the parent company of TCG2602, effective October 1, 2026. Source
• Aratas Corporation is headquartered in Shimogyo-ku, Kyoto, led by President and CEO Masahiko Ezaki, with capital of 1,000 million yen and a March 31 fiscal year-end. Source

Key Takeaways

• The divestment sequence OMRON outlined on March 30, 2026 has now been executed through both the split and the subsequent share transfer, leaving TCG2602 as the 100% holder of Aratas.
• OMRON retains a minority position of 5% in TCG2601, the parent of the acquiring vehicle, rather than exiting the Device & Module Solutions business outright.
• Aratas begins life as a standalone electronic components and electrical machinery business with capital of 1,000 million yen and a Kyoto head office, led by Masahiko Ezaki.
• OMRON stated it will promptly announce any matters requiring disclosure that arise in the future, so questions on proceeds and accounting treatment remain open at this stage.

What OMRON Confirmed About the Share Transfer

The headline event is narrow and fully scheduled. OMRON said the transfer of all issued and outstanding shares of Aratas Corporation to TCG2602 Co., Ltd. was completed effective October 1, 2026. TCG2602 is described as a wholly owned subsidiary of a company established by The Carlyle Group, a term the notice applies to Carlyle entities including affiliate companies and related entities.

The transfer continues a sequence OMRON first disclosed on March 30, 2026. Under that plan, the company moved the shares and assets tied to the Device & Module Solutions business into Aratas, a subsidiary OMRON established, via an absorption-type company split. A second step covered shares, equity interests and assets related to the business held by group companies in various countries and regions, moved into Aratas or into overseas subsidiaries Aratas established through share or equity transfers, asset transfers, business transfers or comparable methods. The final step was the transfer of all Aratas shares to TCG2602.

The company confirmed the split took effect on July 1, 2026, as scheduled. The third step closed with the October 1 completion. No changes to timeline or structure were disclosed in this notice.

Why OMRON Kept a 5% Stake in TCG2601

The structure is not a clean exit. OMRON had already signalled in the March 30 press release that it intended to take a stake in TCG2601 Co., Ltd., the parent company of TCG2602, following the share transfer, so that its shareholding ratio would reach 5%. The notice states that equity investment was completed effective October 1, 2026.

That detail matters for how the transaction reads commercially. OMRON ends the day as the former parent of a divested business and as a minority holder one level above the acquiring vehicle. The notice does not explain the commercial logic behind holding that stake, nor does it disclose the investment amount, the valuation of Aratas, or the proceeds from the share transfer. Any inference about the purpose of the retained interest, whether supply continuity, transition support or a financial carry, would go beyond the source text.

Aratas Corporation at a Glance

The notice provides a factual snapshot of the divested entity. Aratas Corporation is located at 801, Minami Fudondo-cho, Horikawa Higashiiru, Shiokoji-dori, Shimogyo-ku, Kyoto-shi. Its representative is Masahiko Ezaki, President and CEO. Its business is described as manufacture, sales, etc. of electronic components and electrical machinery and equipment. Capital is 1,000 million yen and the fiscal year-end is March 31.

Related: Brainomix Targets U.S. Expansion with £4.8M Series C Extension in 2026

The only listed principal shareholder is TCG2602 Co., Ltd., at 100%. OMRON separately holds 5% of voting rights in TCG2601, one layer up. The location detail is notable because Aratas shares the Kyoto base associated with OMRON's head office in Shimogyo-ku, which the notice itself confirms in identifying OMRON Corporation's headquarters. The notice does not describe Aratas employee numbers, revenue, product lines within the Device & Module Solutions portfolio, or its management team beyond Ezaki.

What This Transaction Changes for OMRON

OMRON's own description of itself in the notice is unchanged: an automation company with core competencies in Sensing & Control + Think technology, operating across industrial automation, healthcare and social systems, established in 1933 and providing products and services in more than 130 countries. The Device & Module Solutions business is no longer part of the group's consolidated perimeter following the split and the share transfer.

What the notice does not provide is equally relevant for anyone modelling the company. There is no disclosure of the Device & Module Solutions unit's financial contribution, no gain or loss figure on the transaction, no update to earnings guidance and no statement on how the proceeds will be used. OMRON wrote only that it will promptly announce any matters requiring disclosure that arise in the future. Until that disclosure arrives, the financial consequence of the transaction for OMRON cannot be established from this source.

For deeper context, see our Cyber Security analysis: "How AI Is Transforming Cybersecurity in 2026: Market Analysis".

OMRON Implementation Risks

The most immediate risk flagged by the structure itself is disclosure sequencing. The notice is titled "Progress of Disclosed Matter," which means it confirms execution against a plan first published on March 30, 2026 rather than announcing a new strategic decision. Investors and counterparties therefore have to watch for follow-on filings covering proceeds, accounting treatment and any remaining matters requiring disclosure, which the company said it would announce promptly.

A second open point is the relationship between OMRON and the divested business. The 5% voting-rights position in TCG2601 creates a continuing link, but the notice does not specify any commercial agreement, supply arrangement, transition services agreement or governance right attached to that holding. Without that detail, the operational separation between OMRON and Aratas cannot be assessed from this document alone, and any assumption about post-closing supply or integration support is unsupported.

What This Means for Practitioners

For procurement teams and enterprise buyers sourcing electronic components and electrical machinery, the practical question is continuity of contract. Counterparties that signed with OMRON's Device & Module Solutions business now face Aratas Corporation as the entity that absorbed it, with a new legal identity, capital base and ownership, while OMRON itself retains only a 5% voting position one level above the acquiring vehicle. Because the notice mentions no assignment terms, novation language or transition arrangement, buyers and their legal teams should verify in writing which entity now holds their agreements, which entity invoices them, and whether any consent or re-papering step is required. That verification is the actionable near-term task supported by this disclosure.

Additional coverage: How AI Automation will Impact Investments Companies in 2026

Editorial independence disclosure: this article was written by Business 2.0 News based solely on OMRON's published notice. No third-party outlet reporting was used, and no source other than the OMRON Global News release linked throughout this article was consulted.

Source note: all facts in this article are drawn from the OMRON Global News notice at https://www.omron.com/global/en/news/2026/10/c1001-2.html, published October 1, 2026. Details not present in that release, including transaction value, proceeds, accounting impact, commercial agreements between OMRON and Aratas, and the composition of Aratas beyond its named representative, are not asserted here.